"Our dedicated and highly skilled physicians and staff, who specialize in caring for adults with cancer and blood disorders, provide unparalleled access to the most innovative, advanced therapies and latest technologies including cutting edge clinical trials. All of the physicians at Illinois Cancer specialists are board certified."

During the past decade, Illinois Cancer Specialists conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 13 clinical trials were completed, i.e. on average, 44.8% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 10 clinical trials were completed. i.e. 52.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois Cancer Specialists" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "NewLink Genetics Corporation" with 4 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois Cancer Specialists" #1 collaborator was "Gynecologic Oncology Group" with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator, "Akesobio Australia Pty Ltd" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Illinois Cancer Specialists" are "Breast Cancer" (4 trials), "Colorectal Cancer" (4 trials), "Ovarian Cancer" (3 trials), "Pancreatic Cancer" (3 trials) and "Cancer" (2 trials). Many other conditions were trialed in "Illinois Cancer Specialists" in a lesser frequency.

Most popular intervention types in "Illinois Cancer Specialists" are "Drug" (36 trials), "Biological" (9 trials), "Other" (2 trials), "Radiation" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (6 trials), "Placebo" (5 trials), "Paclitaxel" (4 trials), "Atezolizumab" (3 trials) and "Bevacizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Illinois Cancer Specialists" are 37 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Illinois Cancer Specialists". undefined are not yet recruiting, 8 are recruiting, 9 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in Illinois Cancer Specialists, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois Cancer Specialists, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".